# LEO Pharma

**Type:** Funders  
**Canonical URL:** https://scholariq.org/funders/leo-pharma/

## Facts

| Field | Value |
| --- | --- |
| Country | DK |
| Description | international pharmaceutical company, based in Denmark |
| OpenAlex ID | https://openalex.org/F4320332071 |
| Works | 3,269 |

## Funder papers

- [Increasing severity of atopic dermatitis is associated with a negative impact on work productivity among adults with atopic dermatitis in France, Germany, the U.K. and the U.S.A.](https://scholariq.org/papers/increasing-severity-of-atopic-dermatitis-is-associated-with-a-negative-impact-on/)
- [Costs and Treatment Patterns Among Patients with Atopic Dermatitis Using Advanced Therapies in the United States: Analysis of a Retrospective Claims Database](https://scholariq.org/papers/costs-and-treatment-patterns-among-patients-with-atopic-dermatitis-using/)
- [Burden of Atopic Dermatitis in Adults in Greece: Results from a Nationwide Survey](https://scholariq.org/papers/burden-of-atopic-dermatitis-in-adults-in-greece-results-from-a-nationwide-survey/)
- [Efficacy and safety of niraparib in patients aged 65 years and older with advanced ovarian cancer: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial](https://scholariq.org/papers/efficacy-and-safety-of-niraparib-in-patients-aged-65-years-and-older-with/)
- [Burden of Disease in Real-Life Setting of Patients With Atopic Dermatitis: Italian Data From the MEASURE-AD Study](https://scholariq.org/papers/burden-of-disease-in-real-life-setting-of-patients-with-atopic-dermatitis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.